Healthcare -
Biotechnology - NASDAQ - GB
$ 28.06
-8.39 %
$ 1.4 B
Market Cap
-27.51
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Immunocore Holdings plc
| Revenue | 310 M |
| Cost Of Revenue | 2.73 M |
| Gross Profit | 307 M |
| Operating Expenses | 378 M |
| Operating Income | -70.5 M |
| Other Expenses | -19.4 M |
| Net Income | -51.1 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 310.2 | 249.4 | 143.7 | 26.5 | 30.1 | 25.7 | 23.7 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 2.7 | 1.0 | 0.5 | 73.2 | 74.8 | 100.0 | 0 |
| Gross Profit | 307.5 | 248.4 | 143.3 | (46.7) | (44.7) | (74.3) | 23.7 |
| OPERATING INCOME | |||||||
| Operating Expenses | 377.9 | 308.0 | 182.9 | 161.7 | 119.4 | 144.2 | 117.7 |
| Selling, General and Administrative Expenses | 155.8 | 144.5 | 93.7 | 88.4 | 45.7 | 44.2 | 34.2 |
| Research and Development Expenses | 222.2 | 163.5 | 89.2 | 73.2 | 74.8 | 100.0 | 83.6 |
| Operating Income | (70.5) | (59.6) | (39.6) | (135.2) | (86.2) | (118.3) | (93.5) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 18.8 | 5.2 | 7.7 | 5.8 | 3.1 | 3.8 | 0.8 |
| Total Other Income | 17.5 | (1.2) | 5.8 | 33.7 | (1.2) | (7.9) | 5.3 |
| Pre-Tax Income | (52.9) | (60.9) | (44.1) | (140.9) | (87.4) | (126.2) | (88.2) |
| NET INCOME | |||||||
| Tax Provision | (1.9) | (5.6) | (2.9) | (9.4) | (13.3) | (22.3) | (16.5) |
| Net Income | (51.1) | (55.3) | (41.2) | (131.5) | (74.1) | (103.9) | (71.6) |
| EPS | 1.02 | 1.13 | 0.9 | 3.1 | 2.33 | 3.81 | 2.62 |